Optimization of deep learning models for the prediction of gene mutations using unsupervised clustering.

Journal: The journal of pathology. Clinical research
Published Date:

Abstract

Deep learning models are increasingly being used to interpret whole-slide images (WSIs) in digital pathology and to predict genetic mutations. Currently, it is commonly assumed that tumor regions have most of the predictive power. However, it is reasonable to assume that other tissues from the tumor microenvironment may also provide important predictive information. In this paper, we propose an unsupervised clustering-based multiple-instance deep learning model for the prediction of genetic mutations using WSIs of three cancer types obtained from The Cancer Genome Atlas. Our proposed model facilitates the identification of spatial regions related to specific gene mutations and exclusion of patches that lack predictive information through the use of unsupervised clustering. This results in a more accurate prediction of gene mutations when compared with models using all image patches on WSIs and two recently published algorithms for all three different cancer types evaluated in this study. In addition, our study validates the hypothesis that the prediction of gene mutations solely based on tumor regions on WSI slides may not always provide the best performance. Other tissue types in the tumor microenvironment could provide a better prediction ability than tumor tissues alone. These results highlight the heterogeneity in the tumor microenvironment and the importance of identification of predictive image patches in digital pathology prediction tasks.

Authors

  • Zihan Chen
    School of Data Science, University of Science and Technology of China, Hefei, PR China.
  • Xingyu Li
    State Key Laboratory of Mechanical Transmission, Chongqing University, Chongqing 400044, China.
  • Miaomiao Yang
    School of Food and Biological Engineering, Jiangsu University, 301 Xuefu Road, Zhenjiang 212013, Jiangsu, China.
  • Hong Zhang
    Department of Anesthesiology and Operation, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
  • Xu Steven Xu
    Clinical Pharmacology and Quantitative Science, Genmab Inc., Princeton, NJ, USA. sxu@genmab.com.